Peter Attia· MD
in higher risk women particularly those that are farther out from the menopause transition or those with established cardiovascular disease these adverse changes you know may outweigh any favorable benefits
Loading…
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
in higher risk women particularly those that are farther out from the menopause transition or those with established cardiovascular disease these adverse changes you know may outweigh any favorable benefits
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
we want to avoid oral estrogens in women with a history of cardiovascular disease blood clots hydroglycerides gallbladder disease or prior breast intermedral cancer